Labmanager Logo
Vector image of a women researcher looking in a microscope with various representations of research images around her

iStock, DrAfter123

Report Calls for Improved Oversight on Chimeric Human-Animal Research

An examination of the conceptual, ethical, and procedural limitations of chimeric research

| 2 min read
Share this Article
Register for free to listen to this article
Listen with Speechify
0:00
2:00

A new report on the ethics of crossing species boundaries by inserting human cells into nonhuman animals—research surrounded by debate—makes recommendations clarifying the ethical issues and calling for improved oversight of this work.

The report, “Creating Chimeric Animals—Seeking Clarity On Ethics and Oversight,” was developed by an interdisciplinary team, with funding from the National Institutes of Health. Principal investigators are Josephine Johnston and Karen Maschke, research scholars at The Hastings Center, and Insoo Hyun, director of the Center for Life Sciences and Public Learning at the Museum of Life Sciences in Boston, formerly of Case Western Reserve University.

Interested in Biopharma News?

Subscribe to our free Biopharma Tools and Techniques newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Advances in human stem cell science and gene editing enable scientists to insert human cells more extensively and precisely into nonhuman animals, creating “chimeric” animals, embryos, and other organisms that contain a mix of human and nonhuman cells.

Many people hope that this research will yield enormous benefits, including better models of human disease, inexpensive sources of human eggs and embryos for research, and sources of tissues and organs suitable for transplantation into humans. 

But there are ethical concerns about this type of research, which raise questions such as whether the moral status of nonhuman animals is altered by the insertion of human stem cells, whether these studies should be subject to additional prohibitions or oversight, and whether this kind of research should be done at all.

The report found that:

  • Animal welfare is a primary ethical issue and should be a focus of ethical and policy analysis as well as the governance and oversight of chimeric research.
  • Chimeric studies raise the possibility of unique or novel harms resulting from the insertion and development of human stem cells in nonhuman animals, particularly when those cells develop in the brain or central nervous system.
  • Oversight and governance of chimeric research are siloed, and public communication is minimal. Public communication should be improved, communication between the different committees involved in oversight at each institution should be enhanced, and a national mechanism created for those involved in oversight of these studies. 
  • Scientists, journalists, bioethicists, and others writing about chimeric research should use precise and accessible language that clarifies rather than obscures the ethical issues at stake. The terms “chimera,” which in Greek mythology refers to a fire-breathing monster, and “humanization” are examples of ethically laden, or overly broad language to be avoided.

- This press release was provided by The Hastings Center

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - December 2024

2025 Industry and Equipment Trends

Purchasing trends survey results

Lab Manager December 2024 Cover Image
Lab Manager Biopharma eNewsletter

Stay Connected with Biopharma News

Click below to subscribe to Biopharma Tools and Techniques eNewsletter!

Subscribe Today